|
I. |
Allergy and Hypersensitivity: New treatments |
|
II. |
Autoimmune diseases: Where
do we stand? |
|
III. |
Tumor Immunity at the crossroads |
|
IV. |
Transplantation Immunology |
|
V. |
Immune tolerance:
Present and future |
|
VI. |
Immunodeficiency: Any news? |
|
VII. |
Infectious Immunology:
Back to the future |
|
VIII. |
Immune-mediated inflammatory diseases |
|
IX. |
Immunodiagnostics and Immunomonitoring |
|
X. |
Mechanisms of immune-associated diseases |
|
XI. |
Vaccines: Prevention or treatment? |
|
XII. |
Therapeutic Immunomodulators |
|
XIII. |
Immunology in the children and
the elderly |
|
XIV. |
Psychoneuroimmunological
diseases |
|
XV. |
Immunomics and Immunomodeling |
|
XVI. |
New directions in
immunotherapy |
|
XVII. |
Who is who in Immunology? |
|
XVIII. |
Should immune-mediated diseases be considered
complex? |
|
XIX. |
Are we ready for
emerging viruses? |
|
XX. |
Do we need biomarkers for immune-mediated diseases? |
|
XXI. |
Diabetes: Prevention or
Cure? |
|
XXII. |
Immunological education:
When should we start? |
|
|
Final Program of IMD
Congress 2007
|